Oluwadamilola Fayanju, MD, MA, MPHS, FACS, Duke University School of Medicine, Durham, NC, outlines key sessions that will be discussed in the upcoming San Antonio Breast Cancer Symposium (SABCS) 2020, these include the impact of the COVID-19 pandemic on breast cancer screening as well as the results of the use of neoadjuvant endocrine therapy during the COVID-19 pandemic in patients who may otherwise have received surgery. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).